Pathology

  • Active Grant Awards

    Dr. Vladimir Badovinac received grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Molecular mechanisms controlling differentiation of memory CD8 T cells. This funding total is $414,335 and is for the period of May 15, 2015 and should be complete by May 31, 2017.

    Dr. Vladimir Badovinac received a Co-PI grant funding with Dr. John Harty from the Department of Microbiology.  The grant was awarded from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID).  The title of this project is Memory CD8 T cell localization and protection from influenza.   This funding total is $1,900,000 and is for the period of November 1, 2014 and should be complete by October 31, 2019.

    Dr. Vladimir Badovinac received an Oberley Seed Grant from the University of Iowa, Holden Comprehensive Cancer Center. The title of this project is Enhancing anti-tumor CD8 T cell responses for immunotherapy. The award is in the amount of $50,000.

    Nicholas Borcherding, a Graduate Research Assistant in Dr. Weizhou Zhang’s research lab, was awarded an American Medical Association Foundation Seed Grant Research Award for 2015. The title of this project is Paracrine non-canonical Wnt signaling in breast cancer. The award total is $4,895 and is for the period of April 1, 2015 and should be complete by March 31, 2016.

    Dr. Aaron Bossler in collaboration with Dr. Guido Tricot (Internal Medicine) received research funding from the Carver College of Medicine, Collaborative Research Grant Program at the University of Iowa. The title of this project is Next-generation sequencing for improved myeloma care in Iowa. The award is in the amount of $50,000 and is for the period of February 1, 2015 and should be complete by March 31, 2017.

    Dr. Alexander Boyden, a Postdoctoral Fellow in Dr. Nitin Karandikar’s research lab, was awarded a National Multiple Sclerosis Society Postdoctoral Fellowship.  The title of this project is The role of CD8+ regulatory T cells in modulating B cell function during EAE.  The award total is $161,218 and is for the period of July 1, 2015 and should be complete by June 30, 2018.

    Dr. Leslie Bruch received a Medical Student Interest Group (MSIG) award from the Intersociety Council for Pathology Information, Inc. (ICPI). This 2014 MSIG award is a useful mechanism to encourage outstanding medical students to consider a career in pathology. The award is in the amount of $1,000.

    Dr. Bradley Ford received funding for a study in collaboration with Cepheid.   This award is in the amount of $57,530.

    Dr. Bradley Ford received funding for a study in collaboration with Accelerate Diagnostics, Inc.   This award is in the amount of $75,179.

    Dr. Marina Ivanovic received one of the first small Thoracic MOG research grants at the University of Iowa. The title of this project is Metastasis-Associated Protein 1 Expression in lung adenocarcinoma. The award is in the amount of $15,000.

    Dr. Nitin Karandikar received a notice of grant funding from the National Multiple Sclerosis Society. The title of this project is Role of CNS-Specific Autoreactive CD8+ T Cells in MS. The amount of this award is $712,800. The period for this project is April 1, 2013 through March 31, 2017.

    Dr. Nitin Karandikar received grant funding from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is CNS-specific Regulatory CD8+ T cells in autoimmune demyelination. The total direct costs for this award are$1,125,000. The period for this project is May 1, 2011 through April 30, 2016.

    Dr. Nitin Karandikar received grant funding from National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Dissecting the Immunologic Basis of Health and Disease. The total direct costs for this award are $845,020. The period for this project is March 1, 2009 through February 28, 2015.

    Dr. C. Michael Knudson received a Donald D. Dorfman Research Award from the Holden Comprehensive Cancer Center at the University of Iowa Health Care. This award is for the best research paper in lymphoma published in 2012 or 2013. The title of the paper is 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines. The award is in the amount of $2,500.

    Dr. C. Michael Knudson received funding under the Carver College of Medicine Internal Funding Opportunity for High Throughput Screening. The award is in the amount of $10,000.

    Dr. Matthew Krasowski received funding for a study in collaboration with Roche Diagnostics Corporation. This funding total is $104,945 and the study began January 28, 2015 and should be completed by January 28, 2017.

    Dr. Kevin Legge received Graduate Student Fellowship funding for Zeb Zacharias from the American Association of Immunologists (AAI). The title of this project is Regulation of the CD8 T cell Response to Lethal Influenza A Virus Infections. The award total is $22,920 and is for the period of September 1, 2015 and should be complete by August 31, 2016.

    Dr. Kevin Legge and Dr. Thomas Waldschmidt received research funding from Iowa State University for the project with the title of Adaptive immunity and protection generated to nanoparticle-based vaccination against influenza virus. The award is in the amount of $18,230.

    Dr. Kevin Legge received grant funding from the National Institutes of Health/National Institute of Alcohol Abuse and Alcoholism (NIH/NIAAA). The title of this project is Chronic Ethanol Consumption and Pulmonary Immune Suppression. This funding total is $396,376 and is for the period of September 5, 2013 and should be complete by August 31, 2015.

    Dr. Deqin Ma received research funding from the Carver College of Medicine, Holden Comprehensive Cancer Center at the University of Iowa. The title of this project is Molecular Studies of Leiomyosarcoma – Identification of Potential Targets for Personalized Medicine. The award is in the amount of $10,000.

    Dr. Ashutosh Mangalam received a notice of grant funding from the National Multiple Sclerosis Society.  The title of this project is Therapeutic potential of combination therapy using Human Gut-derived commensal bacteria and conventional MS drugs.  The amount of this award is $563,264.  The period for this project is April 1, 2015 through March 31, 2018.

    Dr. Steven Moore received funding for a study in collaboration with Sarepta Therapeutics, Inc. The research funding is in the amount of $391,882.

    Dr. Andrean Simons-Burnett received grant funding from the National Institutes of Health/National Institute of Dental & Craniofacial Research (NIH/NIDCR). The title of this project is Role of inflammation in resistance to EGFR inhibitors in head and neck cancer. This funding total is $1,878,808 and is for the period of July 2, 2014 and should be complete by April 30, 2019.

    Dr. Munir Tanas received Sarcoma Pilot Funding from the University of Iowa, Melanoma and Sarcoma Program. The title of this project is Towards the clinical application of WWTR1 and the Hippo pathway in breast cancer:  a translational proposal. The award is in the amount of $30,000.

    Dr. Weizhou Zhang received a Breast Cancer Research Award from the University of Iowa, Holden Comprehensive Cancer Center. The title of this project is Paracrine non-canonical Wnt signaling in breast cancer. The award is in the amount of $50,000 and is for the period of January 1, 2015 and should be completed by December 31, 2016.

    Dr. Weizhou Zhang received an American Cancer Society Institutional Research Grant from the University of Iowa, Holden Comprehensive Cancer Center. The title of this project is Metformin and interleukin-1 signaling in obesity-associated cancer progression. The award is in the amount of $30,000 and is for the period of May 1, 2014 and should be completed by April 30, 2015.

    Dr. Weizhou Zhang received a V Scholar Grant Award from the V Foundation for Cancer Research. The title of this project is Metformin and Nlrc4-inflammasome in obesity-associated cancer progression. The award is in the amount of $200,000.

    Dr. Weizhou Zhang received an Oberley Seed Grant from the University of Iowa, Holden Comprehensive Cancer Center. The title of this project is TREM-1 facilitates pulmonary metastasis of breast cancer. The award is in the amount of $50,000.